Crossmark

Comparison of clinical outcomes between androgen deprivation therapy with up-front abiraterone and bicalutamide for Japanese patients with LATITUDE high-risk prostate cancer in a real-world retrospective analysis

Crossref DOI link: https://doi.org/10.1007/s10147-021-02071-y

Published Online: 2021-11-15

Published Print: 2022-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Naiki, Taku https://orcid.org/0000-0002-7638-6048
Takahara, Kiyoshi

Ito, Toshiki

Nakane, Keita

Sugiyama, Yosuke

Koie, Takuya

Shiroki, Ryoichi

Miyake, Hideaki

Yasui, Takahiro
License Information

Text and Data Mining valid from 2021-11-15

Version of Record valid from 2021-11-15
More Information

Article History

Received: 10 July 2021

Accepted: 2 November 2021

First Online: 15 November 2021

Declarations

:

: The authors have no conflicts of interest to declare.

: This study was approved by the ethics committees of Nagoya City University Graduate School of Medical Sciences, Hamamatsu University School of Medicine, Fujita Health University School of Medicine, and Gifu University. Patients could opt out as outlined on the websites of Nagoya City University Graduate School of Medical Sciences, Hamamatsu University School of Medicine, Fujita Health University School of Medicine, and Gifu University (approval no. 60-21-0018, 2021-042, 21-051, HM20-465). The authors acknowledge that all investigations conformed with ethical principles.

Document is current

Any future updates will be listed below